🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ERP has been a Game Changer in Patient Care at Mayo Clinic Mayo Clinic Department of Surgery Mayo Clinic Comprehensive Cancer Center . Thanks to Ibrahim Gomaa, MD and Research Team

The #RELARC trial was highly-anticipated, but scarcely-discussed online when it was published this Fall. This was a massive effort from 17 hospitals in China that randomized >1000 patients with right-sided colon cancer to either CME or the more-traditional D2 dissection. They

Laparoscopic Adhesiolysis: 1- Scissors ✂️only, 🚫 energy 2- Swimming 🏊‍♂️ maneuver to help create spaces 3- Gentle traction to avoid avulsion injuries 4- Only cut if you see through 👀

Just out gastrojournal.org/article/S0016-… Endoscopic Recurrence Reduced after Extended Mesenteric Resection Multicentre, Randomised Control Trial (6, 12 and 18 months post true Extended Mesenteric Resection) Gastroenterology Nature Reviews Gastroenterology & Hepatology NEJM Nature Medicine The Lancet Gastroenterology & Hepatology

Colorectal cAncer and CrohN's DIsease study (CANDID): An international multicentre retrospective audit - Garoufalia - 2025 - Colorectal Disease - Wiley Online Library onlinelibrary.wiley.com/doi/full/10.11…

Negative pressure wound therapy in emergency laparotomy. The results of the SUNRRISE trial. No benefit from NPWT. jamanetwork.com/journals/jama/…

Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer Primary endpt: pCR RR 2.33 (1.106-4.916) for pCR with chemoRT -> sequential PD-1 blockade vs chemoRT alone More data supporting concurrent timing of IO with RT pubmed.ncbi.nlm.nih.gov/39762418/

Was initially skeptical of IO+RT for MSS rectal cancer, but do think there’s something there. Challenge is to optimize dose/timing/target volume, & patient selection. Tarzan study by Myriam Chalabi used short course RT+atezo/bev resulting in 42% organ preservation at 2 years.

#DCRJournal Visual Abstract | Neoadjuvant Therapy for Colon Cancer: bit.ly/4ghQcvn

If you are like me, this stuff would have blown your mind but also have made you a more responsible fluid prescriber. Spread the word and stop drowning your patients! Justin Morgenstern Haney Mallemat 𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊

Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials - European Journal of Surgical Oncology ejso.com/article/S0748-…

link.springer.com/article/10.100… The first systematic review and meta- analysis manuscript publication Congratulations to the authors Steven D Wexner MD, PhD Julio Mayol Antonino Spinelli American Gastroenterological Association (AGA) The Lancet Gastroenterology & Hepatology Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪 Fernando Gomollón

Congrats to Jyi Cheng Ng, MD (a rising resident in GS at Hopkins!) for helping to define a significant improvement to prognostics in #Rectal #Cancer. academic.oup.com/bjs/article-ab… Mayo Clinic Mayo Clinic Comprehensive Cancer Center

Interesting new Finnish RCT in JAMA Surgery evaluating ICG's impact on anastomotic leak in colon surgery. The results won't make you switch camps, regardless of which one you're in, but they're important: -No difference in AL rates, reoperations, or overall complications between

Here we go again!? #diverticulitis #rct Sigmoid Resection vs Conservative Treatment After Diverticulitis jamanetwork.com/journals/jamas…

Do you agree or not? ASCRS_1 @ACPGBI SAGES is in Tampa in 2026! LASER Focus on Long-Term Outcomes for Diverticular Disease jamanetwork.com/journals/jamas…

Exciting news! Our article on abdominal drains in emergency colorectal surgery received enough views to be a Top Viewed Article. Read it here onlinelibrary.wiley.com/doi/full/10.11… #TopViewedArticle Wiley in research Colorectal Disease Young ESCP escp

🚨 New data on #temporarystomas in #Crohnsdisease: 🔹 Reversal @ 6mo: 30.2% 🔹 Reversal @ 18mo: 56.9% 🔹 Non-reversal: med therapy (39%), unfit (17%), patient's choice (20%) 🔹 Stoma morbidity: 29.4% "Temporary" often isn’t. #IBDsurgery BJS Open Giacomo Calini ZoeGaroufalia Steven D Wexner MD, PhD

#INTESTINE study results are out doi.org/10.1093/bjsope…

⏳ Have you filled out the GRIFF Collaborative survey yet? We’re building global consensus on intestinal failure & fistula care—and your input is key. 📝 It only takes 4 minutes: bit.ly/griff-survey 🔁 RT to help us reach more voices! #GRIFFcollab #ECF #MedTwitter